318 related articles for article (PubMed ID: 23086999)
21. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture.
Dong T; Yan Y; Chai H; Chen S; Xiong X; Sun D; Yu Y; Deng L; Cheng F
Biomed Pharmacother; 2015 Feb; 69():277-84. PubMed ID: 25661370
[TBL] [Abstract][Full Text] [Related]
22. Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes.
Vincent MF; Marangos PJ; Gruber HE; Van den Berghe G
Diabetes; 1991 Oct; 40(10):1259-66. PubMed ID: 1657665
[TBL] [Abstract][Full Text] [Related]
23. Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth.
Hitosugi T; Kang S; Vander Heiden MG; Chung TW; Elf S; Lythgoe K; Dong S; Lonial S; Wang X; Chen GZ; Xie J; Gu TL; Polakiewicz RD; Roesel JL; Boggon TJ; Khuri FR; Gilliland DG; Cantley LC; Kaufman J; Chen J
Sci Signal; 2009 Nov; 2(97):ra73. PubMed ID: 19920251
[TBL] [Abstract][Full Text] [Related]
24. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1.
Luo W; Hu H; Chang R; Zhong J; Knabel M; O'Meally R; Cole RN; Pandey A; Semenza GL
Cell; 2011 May; 145(5):732-44. PubMed ID: 21620138
[TBL] [Abstract][Full Text] [Related]
25. Development of isoselenazolium chlorides as selective pyruvate kinase isoform M2 inhibitors.
Dimitrijevs P; Makrecka-Kuka M; Bogucka A; Hyvönen M; Pantelejevs T; Arsenyan P
Eur J Med Chem; 2023 Sep; 257():115504. PubMed ID: 37216812
[TBL] [Abstract][Full Text] [Related]
26. Pyruvate kinase M2 mediates fibroblast proliferation to promote tubular epithelial cell survival in acute kidney injury.
Ye Y; Xu L; Ding H; Wang X; Luo J; Zhang Y; Zen K; Fang Y; Dai C; Wang Y; Zhou Y; Jiang L; Yang J
FASEB J; 2021 Jul; 35(7):e21706. PubMed ID: 34160104
[TBL] [Abstract][Full Text] [Related]
27. Pyruvate kinase M2 at a glance.
Yang W; Lu Z
J Cell Sci; 2015 May; 128(9):1655-60. PubMed ID: 25770102
[TBL] [Abstract][Full Text] [Related]
28. The Warburg Effect Mediator Pyruvate Kinase M2 Expression and Regulation in the Retina.
Rajala RV; Rajala A; Kooker C; Wang Y; Anderson RE
Sci Rep; 2016 Nov; 6():37727. PubMed ID: 27883057
[TBL] [Abstract][Full Text] [Related]
29. Nonmetabolic functions of pyruvate kinase isoform M2 in controlling cell cycle progression and tumorigenesis.
Lu Z
Chin J Cancer; 2012 Jan; 31(1):5-7. PubMed ID: 22200182
[TBL] [Abstract][Full Text] [Related]
30. PAICS as a potential target for cancer therapy linking purine biosynthesis to cancer progression.
Huo A; Xiong X
Life Sci; 2023 Oct; 331():122070. PubMed ID: 37673296
[TBL] [Abstract][Full Text] [Related]
31. Screening for adenylosuccinate lyase deficiency using tandem mass spectrometry analysis of succinylpurines in neonatal dried blood spots.
Zikanova M; Krijt J; Skopova V; Krijt M; Baresova V; Kmoch S
Clin Biochem; 2015 Jan; 48(1-2):2-7. PubMed ID: 25445730
[TBL] [Abstract][Full Text] [Related]
32. Emerging roles of PKM2 in cell metabolism and cancer progression.
Luo W; Semenza GL
Trends Endocrinol Metab; 2012 Nov; 23(11):560-6. PubMed ID: 22824010
[TBL] [Abstract][Full Text] [Related]
33. Inherent properties of adenylosuccinate lyase could explain S-Ado/SAICAr ratio due to homozygous R426H and R303C mutations.
Ray SP; Duval N; Wilkinson TG; Shaheen SE; Ghosh K; Patterson D
Biochim Biophys Acta; 2013 Aug; 1834(8):1545-53. PubMed ID: 23714113
[TBL] [Abstract][Full Text] [Related]
34. The AMP-activated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-b-D-ribonucleoside, regulates lactate production in rat Sertoli cells.
Galardo MN; Riera MF; Pellizzari EH; Cigorraga SB; Meroni SB
J Mol Endocrinol; 2007 Oct; 39(4):279-88. PubMed ID: 17909267
[TBL] [Abstract][Full Text] [Related]
35. Increased M2 Isoform of Pyruvate Kinase in Fibroblasts Contributes to the Growth, Aggressiveness, and Osteoclastogenesis of Odontogenic Keratocysts.
Zou Y; Wang R; Zhao J; Cai Y; Zhong W
Am J Pathol; 2021 May; 191(5):857-871. PubMed ID: 33640318
[TBL] [Abstract][Full Text] [Related]
36. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
Mazurek S
Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581
[TBL] [Abstract][Full Text] [Related]
37. The rate of cell growth is regulated by purine biosynthesis via ATP production and G(1) to S phase transition.
Kondo M; Yamaoka T; Honda S; Miwa Y; Katashima R; Moritani M; Yoshimoto K; Hayashi Y; Itakura M
J Biochem; 2000 Jul; 128(1):57-64. PubMed ID: 10876158
[TBL] [Abstract][Full Text] [Related]
38. Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth.
Sun Q; Chen X; Ma J; Peng H; Wang F; Zha X; Wang Y; Jing Y; Yang H; Chen R; Chang L; Zhang Y; Goto J; Onda H; Chen T; Wang MR; Lu Y; You H; Kwiatkowski D; Zhang H
Proc Natl Acad Sci U S A; 2011 Mar; 108(10):4129-34. PubMed ID: 21325052
[TBL] [Abstract][Full Text] [Related]
39. Estradiol-17β upregulates pyruvate kinase M2 expression to coactivate estrogen receptor-α and to integrate metabolic reprogramming with the mitogenic response in endometrial cells.
Salama SA; Mohammad MA; Diaz-Arrastia CR; Kamel MW; Kilic GS; Ndofor BT; Abdel-Baki MS; Theiler SK
J Clin Endocrinol Metab; 2014 Oct; 99(10):3790-9. PubMed ID: 24471565
[TBL] [Abstract][Full Text] [Related]
40. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth.
Christofk HR; Vander Heiden MG; Harris MH; Ramanathan A; Gerszten RE; Wei R; Fleming MD; Schreiber SL; Cantley LC
Nature; 2008 Mar; 452(7184):230-3. PubMed ID: 18337823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
